| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | ORGANON USA INC | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
Follistim is owned by Organon Usa Inc.
Follistim contains Follitropin Alfa/Beta.
Follistim has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Follistim are:
- US5767251
Follistim was authorised for market use on 29 September, 1997.
Follistim is available in injectable;im-sc dosage forms.
The generics of Follistim are possible to be released after 16 June, 2015.
Drugs and Companies using FOLLITROPIN ALFA/BETA ingredient
Market Authorisation Date: 29 September, 1997
Treatment: NA
Dosage: INJECTABLE;IM-SC
More Information on Dosage
FOLLISTIM family patents
